{
    "code": "52027532",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027532",
    "time": "2024-01-04 21:12:22",
    "許可證字號": "衛部藥輸字第027532號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/11\/08",
    "發證\/登錄日期": "107\/11\/08",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202753201",
    "中文品名": "嬡倍斯靜脈凍晶注射劑",
    "英文品名": "Pemetrexed lyophilized powder for concentrate for solution for infusion &quot;CYH&quot;",
    "適應症": "1.Pemetrexed併用Cisplatin是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第一線化療用藥。2.Pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.Pemetrexed單一藥物是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第二線治療用藥。4.Pemetrexed與Cisplatin併用於治療惡性肋膜間質細胞瘤。",
    "劑型": "243凍晶注射劑",
    "包裝": "100毫克、500毫克玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥;",
    "監視期限": "",
    "主成分略述": "PEMETREXED DISODIUM HEMIPENTAHYDRATE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "中化裕民健康事業股份有限公司",
    "申請商地址": "台北市中正區襄陽路23號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "ONCOMED MANUFACTURING A.S.",
            "製造廠廠址": "KARASEK 2229\/1B, BUDOVA 02, 62100 BRNO-RECKOVICE, CZECH REPUBLIC",
            "製造廠公司地址": "",
            "製造廠國別": "CZECH REPUBLIC",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "中國化學製藥股份有限公司新豐工廠",
            "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002430",
            "成分名稱": "PEMETREXED DISODIUM HEMIPENTAHYDRATE",
            "含量描述": "(eq. to Pemetrexed.....100mg)",
            "含量": "120.8100000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1004002430",
            "成分名稱": "PEMETREXED DISODIUM HEMIPENTAHYDRATE",
            "含量描述": "(eq. to Pemetrexed.....500mg)",
            "含量": "604.0700000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "500mg藥品外觀-108-03-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027532&Seq=002&Type=10"
        },
        {
            "title": "100mg藥品外觀-108-03-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027532&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛部藥輸字第027532號-中文仿單-嬡倍斯靜脈凍晶注射劑-108-03-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027532&Seq=001&Type=9"
        },
        {
            "title": "衛部藥輸字第027532號-外盒及標籤-嬡倍斯靜脈凍晶注射劑l500mg-108-03-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027532&Seq=002&Type=8"
        },
        {
            "title": "衛部藥輸字第027532號-外盒及標籤-嬡倍斯靜脈凍晶注射劑l100mg-108-03-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027532&Seq=001&Type=8"
        }
    ]
}